Popular Over-The-Counter Drug Can Slow the Spread of Breast, Bowel and Prostate Cancers

Breast cancer rates are on the rise for women under 40 in the US, with recent research showing they have increased by more than 0.5% per year in 21 states.

Additionally, prostate cancer rates have increased by 2% to 3% annually, and colon cancer rates have risen by 1% to 2% per year among individuals younger than 55, data shows.

Now, a new study has identified one popular drug as a potential agent in slowing the progression of certain cancers — including those of the breast, bowel and prostate — and the best part is that it’s available over the counter.

Aspirin can help the immune system fight cancer spread by blocking a chemical (TXA2), made by blood platelets, that would otherwise weaken the body’s T cells, which are important for attacking cancer cells, the study found.

Previous research has indicated that aspirin has the potential to slow the progression of some cancers.

A 2021 analysis that reviewed 13 studies with over 140,000 breast cancer patients found that aspirin use was linked to a 31% reduction in breast cancer-specific mortality and a 9% decrease in recurrence or metastasis risk. (Read more from “Popular Over-The-Counter Drug Can Slow the Spread of Breast, Bowel and Prostate Cancers” HERE)